#Myocarditis

SciencePosted by
NBC News

Evidence grows stronger for Covid vaccine link to heart issue, CDC says

A higher-than-usual number of cases of a type of heart inflammation has been reported following Covid-19 vaccination, especially among young men following their second dose of an mRNA vaccine, the Centers for Disease Control and Prevention said Thursday. Overall, 226 cases of myocarditis or pericarditis after vaccination in people younger...
Picture for Evidence grows stronger for Covid vaccine link to heart issue, CDC says
TRENDING TOPICS
Columbia, SCWIS-TV

DHEC responds to myocarditis trend in younger vaccine recipients

COLUMBIA, S.C. (WIS) - The CDC has scheduled an emergency meeting for June 18 to review 475 reports nationwide that contain information about myocarditis following COVID-19 vaccinations. SCDHEC says that instances of myocarditis are not increased overall, but cases are now being seen more in the younger age group of...
Medical ScienceWebMD

Evidence Ties COVID Vaccines to Heart Issue in Youth

June 11, 2021 -- Swelling of the heart appears to be a very rare side effect that primarily strikes young people after vaccination for COVID-19, a CDC expert reported Thursday, detailing data on cases of myocarditis and pericarditis found through a government safety system. The side effect seems to be...
Public HealthMedscape News

EMA Seeks More Data on Myocarditis After COVID-19 Shots

The European Medicines Agency (EMA) safety committee is continuing its review of myocarditis and pericarditis following vaccination with COVID-19 vaccines. "Currently, further analysis is needed to conclude whether there is a causal relationship with the vaccines, and the PRAC requesting additional data from the companies marketing them," the EMA said in a statement issued Friday.
Diseases & TreatmentsMedical News Today

Everything to know about giant-cell myocarditis

Myocarditis occurs when there is inflammation in the heart muscle. Giant-cell myocarditis (GCM) develops when this inflammation results in abnormal growth of cells. These then cause more inflammation to the heart, damaging it further. A number of conditions can lead to myocarditis. GCM, however, has no known cause. GCM is...
Public Healthaappublications.org

Report details 7 cases of myocarditis after COVID-19 vaccination

Editor’s note:For the latest news on COVID-19, visit http://bit.ly/AAPNewsCOVID19. A new report takes a close look at seven teen boys who developed myocarditis after COVID-19 vaccination, each of whom had similar symptoms, timing and outcomes. While health officials investigate whether vaccination caused this condition, Judith A. Guzman-Cottrill, D.O., a corresponding...
Public Healthct.gov

What to Know about Myocarditis after COVID-19 vaccination

On May 27th, the Centers for Disease Control and Prevention issued guidance for parents/patients regarding reports of a small number of individuals nationally who developed a rare condition known as myocarditis after recently being vaccinated for COVID-19. The CDC, and DPH, continue to encourage everyone 12 and older to get...
Diseases & TreatmentsNBC Connecticut

What You Should Know About Myocarditis

At least 18 teens and young adults in Connecticut have shown symptoms of heart problems after receiving the COVID-19 vaccine, according to officials from the state Department of Public Health. This is what you need to know. Health officials said the reported cases appear to be mild and typically begin...
POTUSPosted by
CNN

A link between Covid-19 vaccination and a cardiac illness may be getting clearer

(CNN) — Vaccine advisers to the US Centers for Disease Control and Prevention say there has been a higher-than-expected number of cases of a heart ailment among young people, most often males, who've recently received their second doses of the Pfizer and Moderna Covid-19 vaccines. The CDC says the reports of the ailment are "rare" and that "most patients who received care responded well to medicine and rest and quickly felt better."
Healthcontagionlive.com

FDA VRBPAC Meeting Covers Myocarditis, Data in Pediatric Population, Immunobridging

The committee members discussed their concerns about having sufficient data to make an informed decision around the risk vs. benefits for looking at potential FDA approvals for vaccines in this population group. The FDA Vaccines and Related Biological Products Advisory Committee (VRBPAC) met on Thursday to discuss COVID-19 vaccines in...
YOU MAY ALSO LIKE